About Accutest Global
Accutest Global is a company based in Mumbai (India) founded in 1998 was acquired by Florintree in October 2022. The company has 18 employees as of July 25, 2024. Accutest Global offers products and services including BA/BE Studies, Clinical Development Services, and Biologics Characterization. Accutest Global operates in a competitive market with competitors including Emmes, Syneos Health, Veristat, ClinChoice and Medelis WCCT Global, among others.
- Headquarter Mumbai, India
- Employees 18 as on 25 Jul, 2024
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Accutest Research Laboratories India Private Limited
- Date of Incorporation 08 Mar, 2001
- Jurisdiction Thane, Maharashtra, India
-
Annual Revenue
$9.45 M (USD)-11.4as on Mar 31, 2023
-
Net Profit
$3.69 M (USD)259.85as on Mar 31, 2023
-
EBITDA
$110.7 K (USD)-75.48as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Greater Pacific Capital
& 1 more
-
Employee Count
18
as on Jul 25, 2024
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Accutest Global
Accutest Global offers a comprehensive portfolio of products and services, including BA/BE Studies, Clinical Development Services, and Biologics Characterization.
Conducts pharmacokinetic studies for generics and biosimilars.
Manages phases II to IV studies for small and large molecules.
Performs immunogenicity and clinical comparability studies.
People of Accutest Global
Unlock access to complete
Funding Insights of Accutest Global
Detailed funding history for Accutest Global
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Accutest Global
Accutest Global has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Greater Pacific Capital and Florintree.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment management firm specializing in Asia, India, and impact investing services.
|
Locked | Locked | Locked | |
|
Privat equity firm
|
Locked | Locked | Locked |
Investor details for Accutest Global
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Accutest Global
Investment portfolio details for Accutest Global
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Accutest Global
Detailed financials for Accutest Global
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Accutest Global Comparisons
Peer comparison for Accutest Global
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Accutest Global
Accutest Global operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Emmes, Syneos Health, Veristat, ClinChoice and Medelis WCCT Global, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Outsourced contract research organization services are provided to clients.
|
|
| Locked | Locked | Locked |
CRO clinical development services are provided by Syneos Health.
|
|
| Locked | Locked | Locked |
Clinical trials and regulatory submissions are supported as a CRO.
|
|
| Locked | Locked | Locked |
CRO focused on data management, regulatory affairs and consulting services
|
|
| Locked | Locked | Locked |
Full-service CRO expertise in influenza and oncology research is offered.
|
|
| Locked | Locked | Locked |
Therapies for cancer and inflammatory diseases are developed.
|
Detailed competitors of Accutest Global
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Accutest Global
Complete news archive for Accutest Global
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Accutest Global
Accutest Global was founded in 1998.
Accutest Global is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
As of Jul 25, 2024, the latest employee count at Accutest Global is 18.
Annual revenue of Accutest Global is $9.45M as on Mar 31, 2023.
Accutest Global was founded in 1998 as an independent contract research organization based in Mumbai, India. Services in bioavailabilitybioequivalence studies and Phase II-IV clinical development are provided, along with analytical characterization for biosimilars, novel biologics, and complex generics. Operations are conducted in India, Brazil, and Mexico to serve international clients. More than 2200 BABE studies and 550 ANDA filings have been completed.
Accutest Global's top competitors include Emmes, Syneos Health and ClinChoice.
Accutest Global offers BA/BE Studies, Clinical Development Services, and Biologics Characterization.
Accutest Global has 2 investors. Key investors include Greater Pacific Capital, and Florintree.